45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
9,074
Insurances with rates
3
CPT / HCPCS codes
8,150
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J9228 | IPILIMUMAB 5 MG/ML INJECTION (SO) | $119,455 | $47,782 | — | — | 12 |
| J9269 | TAGRAXOFUSP-ERZS 1,000 MCG/ML INTRAVENOUS SOLUTION | $108,194 | $43,278 | — | — | 6 |
| J2507 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $100,211 | $40,084 | — | — | 12 |
| J3357 | USTEKINUMAB 90 MG/ML SUBCUTANEOUS SYRINGE | $97,450 | $38,980 | — | — | 6 |
| J9281 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT | $82,845 | $33,138 | — | — | 5 |
| C2616 | YTTRIUM-90 BRACHYTX SRC NON-STRANDED | $79,875 | $31,950 | — | — | 6 |
| A9543 | Y-90 ZEVALIN | $70,810 | $28,324 | — | — | 5 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $69,000 | $27,600 | — | — | 6 |
| 33276 | HC INSERT PHRENIC NERVE STIM SYS W/ IMAGING GDNCE | $67,856 | $27,142 | — | — | 5 |
| 33287 | HC RMVL & REPLCMNT PHRENIC NERVE STIM PULSE GEN | $67,856 | $27,142 | — | — | 5 |
| J7311 | FLUOCINOLONE 0.59 MG INTRAVITREAL IMPLANT | $66,588 | $26,635 | — | — | 6 |
| J9266 | PEGASPARGASE 750 UNIT/ML INJECTION SOLUTION | $65,105 | $26,042 | — | — | 5 |
| J3245 | TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE | $60,331 | $24,132 | — | — | 6 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION | $55,721 | $22,288 | — | — | 6 |
| J9298 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $50,864 | $20,345 | — | — | 6 |
| J9307 | PRALATREXATE 40 MG/2 ML (20 MG/ML) INTRAVENOUS SOLUTION | $47,513 | $19,005 | — | — | 6 |
| J0896 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION | $40,697 | $16,279 | — | — | 6 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $39,557 | $15,823 | — | — | 6 |
| J9043 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $37,846 | $15,138 | — | — | 5 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $37,121 | $14,848 | — | — | 6 |
| J2329 | UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION | $36,654 | $14,662 | — | — | 6 |
| J1640 | HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION | $36,447 | $14,579 | — | — | 12 |
| J9119 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $34,993 | $13,997 | — | — | 5 |
| A9604 | SAMARIUM-153 LEXIDRONAM | $34,493 | $13,797 | — | — | 5 |
| J2327 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $34,321 | $13,728 | — | — | 5 |
| J9203 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $34,126 | $13,650 | — | — | 6 |
| J9144 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $33,926 | $13,570 | — | — | 6 |
| J1932 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE | $31,124 | $12,450 | — | — | 6 |
| J3380 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $30,333 | $12,133 | — | — | 6 |
| 0620T | HC REVASC VENOUS TIB/PER ARTERIALIZATION | $29,831 | $11,932 | — | — | 5 |
| C9047 | CAPLACIZUMAB-YHDP 11 MG INJECTION KIT | $28,847 | $11,539 | — | — | 6 |
| J9301 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $28,846 | $11,539 | — | — | 6 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $28,733 | $11,493 | — | — | 6 |
| J0475 | BACLOFEN 2,000 MCG/ML INTRATHECAL SOLUTION | $28,354 | $11,342 | — | — | 23 |
| J9223 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION | $27,825 | $11,130 | — | — | 5 |
| J0180 | AGALSIDASE BETA 35 MG INTRAVENOUS SOLUTION | $26,092 | $10,437 | — | — | 6 |
| J1930 | LANREOTIDE 90 MG/0.3 ML SUBCUTANEOUS SYRINGE | $25,988 | $10,395 | — | — | 12 |
| 33277 | HC INSERT PHRENIC NERVE STIM TRANSVEN SENSING LEAD | $25,919 | $10,368 | — | — | 5 |
| 33288 | HC RMVL & REPLCMNT PHRENIC NERVE STIM TRANSVEN LEAD(S) | $25,919 | $10,368 | — | — | 5 |
| 92972 | HC CORONARY LITHOTRIPSY | $25,852 | $10,341 | — | — | 5 |
| J9308 | RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION | $24,994 | $9,998 | — | — | 12 |
| J1459 | IMMUNE GLOB,GAMM(IGG) 10 %-PRO-IGA 0 TO 50 MCG/ML INTRAVENOUS SOLUTION | $24,632 | $9,853 | — | — | 48 |
| J9273 | TISOTUMAB VEDOTIN-TFTV 40 MG INTRAVENOUS SOLUTION | $23,097 | $9,239 | — | — | 5 |
| J9311 | RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN | $23,018 | $9,207 | — | — | 6 |
| J9306 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION | $22,844 | $9,138 | — | — | 6 |
| J1300 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION | $22,830 | $9,132 | — | — | 6 |
| J2506 | PEGFILGRASTIM 6 MG/0.6 ML SUBCUTANEOUS SYRINGE | $22,463 | $8,985 | — | — | 6 |
| J1303 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION | $22,414 | $8,966 | — | — | 12 |
| J0850 | CYTOMEGALOVIRUS IMMUNE GLOBULIN 50 MG/ML INTRAVENOUS SOLUTION | $22,221 | $8,888 | — | — | 6 |
| J9354 | ADO-TRASTUZUMAB EMTANSINE 160 MG INTRAVENOUS SOLUTION | $21,794 | $8,718 | — | — | 6 |
Showing top 50 of 9,074 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.